The direct association of TNF-α with the pathogenesis of the disease is evidenced by its increased levels in the lesional tissue, peripheral blood and saliva of patients with OLP which is reduced by corticosteroid, immunosuppressive and anti-TNF-α therapy [124,125,126]. Here, TNF is linked to oral lichen planus.